▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #2991 by analyst upside · 2026-11-12
CBLL
CeriBell, Inc.
Healthcare · Market Cap $1B · P/E 0x
ANALYST PRICE TARGET
+13.6%
implied upside to consensus target
Current Price $27.8
Consensus Target $31.57
Bull Target $33.0
Bear Target $30.0
Analysts Covering 7
ANALYST CONSENSUS - BUY
Strong Buy
1
Buy
6
Hold
0
Sell
0
52-Week Low $12.36
52-Week High $28.89
YTD Return +30.5%
FUNDAMENTALS
Market Cap $1B
P/E Ratio (TTM) N/A
Forward P/E N/A
EPS (TTM) $-1.97
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $109M
Profit Margin -68.0%
52-WEEK RANGE
52-Week Low $12.36
52-Week High $28.89
Current Price $27.8
Bear Target $30.0
Bull Target $33.0
● Now $27.8 ● Target $31.57
TRADING DATA
Avg Volume 450K
YTD Return +30.5%
Analyst Count 7
Consensus Buy
Upside to Target +13.6%
Last Updated 2026-11-12

ANALYST SUMMARY

CeriBell, Inc. (CBLL) is currently trading at $27.8 with a Wall Street consensus price target of $31.57, implying potential upside of 13.6% over the next 12 months. 7 analysts currently cover CBLL, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $33.0, while the most cautious has a target of $30.0.

CBLL operates in the Healthcare sector with a market capitalisation of $1B. The stock is up 30.5% year-to-date and is currently trading near the upper end of its 52-week range of $12.36 – $28.89.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for CBLL, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Canaccord Genuity - Reiterated
Buy → Buy 2026-11-04 Building track record
TD Cowen - Reiterated
Buy → Buy 2026-10-02 Building track record
BTIG reit
Buy → Buy 2026-09-11 38% win rate (8 calls)
BTIG - Reiterated
Buy → Buy 2026-08-18 38% win rate (8 calls)
Canaccord Genuity - Reiterated
Buy → Buy 2026-08-11 Building track record
BTIG reit
Buy → Buy 2026-08-11 38% win rate (8 calls)
Canaccord Genuity - Reiterated
Buy → Buy 2026-05-12 Building track record
BTIG reit
Buy → Buy 2026-01-28 38% win rate (8 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
71
out of 100
Coverage depth
16/30
Consensus clarity
28/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →